INKT logo

MiNK Therapeutics, Inc.

INKT
Healthcare|Biotechnology|US
$10.35
+0.30 (+2.99%)
DCF Value
$1.16
Cash / Share
$1.75
Next Earnings Report
Nov 11, 2026
EPS est. -$0.66 · Revenue est. $75.0K
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Dec 10, 2025 (S-3/A). Possible dilution.

Upcoming Data Readouts (1)

Jun 2027
Est. completion
P2Pneumonia
A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure
NCT07615010n=90

Recent Press Releases

MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell Therapy Targets Two Key Mechanisms of Tumor Resistance Presented at the Society of Immunotherapy of Cancer (SITC 2026)
Nov 6, 2026 · GlobeNewsWire
MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy
Nov 2, 2026 · GlobeNewsWire
MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026
Oct 2, 2026 · GlobeNewsWire
MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy
Sep 30, 2026 · GlobeNewsWire
MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury
Aug 13, 2026 · GlobeNewsWire

SEC Filings (39)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Aug 13, 2026S-8Employee stock planDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Jun 23, 20268-KMaterial eventDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 15, 20268-KMaterial eventDocumentIndex
Apr 30, 2026ARSAnnual report to holdersDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 31, 202610-KAnnual reportDocumentIndex
Mar 31, 20268-KMaterial eventDocumentIndex
Mar 27, 20268-KMaterial eventDocumentIndex
Mar 19, 20268-KMaterial eventDocumentIndex
Jan 2, 20268-KMaterial eventDocumentIndex
Dec 11, 2025EFFECTDocumentIndex
Dec 10, 2025S-3/AShelf registrationDocumentIndex
Dec 8, 20258-KMaterial eventDocumentIndex
Nov 14, 202510-QQuarterly reportDocumentIndex
Nov 7, 2025S-3Shelf registrationDocumentIndex
Sep 29, 20258-KMaterial eventDocumentIndex
Aug 22, 2025424B5Offering prospectusDocumentIndex
Aug 14, 2025S-8Employee stock planDocumentIndex
Aug 14, 202510-QQuarterly reportDocumentIndex
Aug 14, 20258-KMaterial eventDocumentIndex
Jul 15, 20258-KMaterial eventDocumentIndex
Jul 15, 2025424B5Offering prospectusDocumentIndex
Jul 14, 20258-KMaterial eventDocumentIndex
Jun 18, 20258-KMaterial eventDocumentIndex
May 15, 202510-QQuarterly reportDocumentIndex
May 15, 20258-KMaterial eventDocumentIndex
Apr 30, 2025ARSAnnual report to holdersDocumentIndex
Apr 30, 2025DEF 14AProxy / shareholder voteDocumentIndex
Apr 18, 2025PRE 14AProxy / shareholder voteDocumentIndex
Mar 18, 202510-KAnnual reportDocumentIndex
Mar 18, 20258-KMaterial eventDocumentIndex
Jan 21, 20258-KMaterial eventDocumentIndex
Dec 20, 2024DEF 14AProxy / shareholder voteDocumentIndex
Dec 6, 2024PRE 14AProxy / shareholder voteDocumentIndex
Nov 14, 202410-QQuarterly reportDocumentIndex
Nov 14, 20248-KMaterial eventDocumentIndex